Pulmonx Corporation is a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD), offering products like the Zephyr® Endobronchial Valve and Chartis® Pulmonary Assessment System
Pulmonx Corporation is a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD), offering products like the Zephyr® Endobronchial Valve and Chartis® Pulmonary Assessment System.